Delivery Order SPE2DB20D2104-SPE2DB25FMXPT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,817.86 to AmerisourceBergen Drug Corp for Motegrity 2 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supply on August 25, 2025, with an ultimate completion date of August 26, 2025. This contract, valued at $2,857.19, covers the delivery of Motegrity 2 mg tablets (30-count units) and represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on June 25, 2025, valued at $2,324.64 with a firm fixed price structure. The contract calls for the delivery of Motegrity 1 mg tablets in quantities of 30, with performance to be completed at the contractor's Conshohocken facility by June 26, 2025. This delivery order was competitively awarded with no set-aside designation...
- The Defense Logistics Agency awarded a $3,041.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561835865 Motegrity 2 mg tablets in quantities of 30 tablets. Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 17, 2023 in performance of this order. As the prime contractor, Amerisourcebergen Drug Corporation will utilize its corporate distribution infrastructure and capabilities...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Motegrity 2 mg tablets to the Defense Medical Logistics Standard Support (DMLSS) program. The $4,891.22 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 9, 2021. The contract has a completion date of September 10, 2021 and was not designated with a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Motegrity 2 mg tablets. The $18,831.57 firm fixed-price delivery order is a part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by AmerisourceBergen's parent company, Cencora, Inc., which runs through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to supply a...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $678.75 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 30 tablets of the 2 mg dosage of the prescription medication Motegrity. Performance will take place in Conshohocken, Pennsylvania over one day in July 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring and providing medical supplies and...
- This is a delivery order contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,901.65, is for the supply of Motegrity 2 mg tablets to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for 90 tablets of Gemtesa 75 mg, with a ceiling value of $5,400.07 under a firm fixed-price delivery order contract. The award was competitively procured with no set-aside designation and is scheduled for completion by September 16, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,659.20 order is for the delivery of the pharmaceutical product MOTEGRITY 1 MG TABLET to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used. This delivery order falls under a larger indefinite delivery contract...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXPTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for Motegrity (1 mg tablets, 30-count) with a ceiling value of $1,099.70 under a firm fixed-price contract type. This award represents a competitive procurement with no set-aside designation and is scheduled for completion by August 13, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen supplies a broad portfolio of medications and medical products to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The company's extensive federal contract history demonstrates its capability to fulfill varied pharmaceutical procurement requirements across multiple therapeutic domains through competitive, firm fixed-price delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/12/25 |